45
9
13
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8839 |
ICCB280
|
Apoptosis; Others | Apoptosis; Others |
ICCB280 是一种 C/EBPα诱导剂,通过激活 C/EBPα 并影响其下游靶点,具有终末分化、增殖停滞和凋亡的抗白血病特性。 | |||
T6641 |
Rilmenidine Phosphate
|
Apoptosis; Adrenergic Receptor; Autophagy; Imidazoline Receptor | Apoptosis; Autophagy; GPCR/G Protein; Neuroscience |
Rilmenidine phosphate 是一种新型的抗高血压药物和口服活性选择性 I1 咪唑啉受体激动剂。它可调节白血病细胞增殖,刺激促凋亡蛋白 Bax,从而诱导人白血病 K562 细胞线粒体通路的紊乱和凋亡。它可通过减少交感神经过度活跃而发挥中枢作用,并通过抑制 Na+/H+反向转运而在肾脏中发挥作用。 | |||
T3278 |
Piribedil
EU-4200,Trivastan,ET-495,Trivastal |
Dopamine Receptor; Histone Methyltransferase; Adrenergic Receptor | Chromatin/Epigenetic; GPCR/G Protein; Neuroscience |
Piribedil (Trivastan) 是多巴胺 D2受体激动剂,对 hα1A-肾上腺素受体也显示出拮抗作用。 | |||
T12575 |
Unesbulin
PTC596 |
Apoptosis; BMI-1 | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Unesbulin (PTC596) 是一种口服有效和选择性的 B 细胞特异性莫洛尼氏鼠白血病病毒整合位点 1 抑制剂。它在急性髓细胞白血病细胞中可下调 MCL-1 并诱导不依赖 p53 的线粒体凋亡,具有抗白血病作用。 | |||
T8531 |
m-3M3FBS
2,4,6-三甲基-N-[3-(三氟甲基)苯基]苯磺酰胺 |
Apoptosis; Phospholipase | Apoptosis; Metabolism |
m-3M3FBS 是一种有效的磷脂酶C 激活剂,刺激人中性粒细胞产生超氧物,上调细胞内钙离子浓度,刺激多种细胞产生磷酸肌醇。它诱导单核细胞白血病细胞凋亡。 | |||
T4215 |
TCS-PIM-1-4a
5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮,SMI-4a |
Apoptosis; Pim | Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling |
TCS-PIM-1-4a (SMI-4a) 是一种泛-Pim 激酶抑制剂,可通过激活 AMPK 来阻断 mTORC1的活性。它可杀死多种髓样和淋巴样细胞系,IC50值为 0.8 μM 至 40 μM。 | |||
T12708 |
Resveratrol analog 1
|
Mitophagy; IκB/IKK; Sirtuin; Autophagy | Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; NF-κB |
Resveratrol analog 1 是天然产物白藜芦醇的类似物,具有比白藜芦醇更显著的抗白血病活性。 | |||
T14550 |
BETd-260
ZBC 260 |
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
BETd-260是一种 PROTAC,由 Cereblon 配体和 BET 配体相连,对白血病细胞株 BRD4蛋白的抑制作用。 | |||
T11766L |
Eltanexor
ONO-7706,KPT-8602,ATG-016 |
Others | Others |
Eltanexor (ONO-7706) 是一种具有口服活性的 exportin-1 (XPO1) 抑制剂。它具有有效的抗白血病活性。 Eltanexor 通过直接靶向 XPO1 抑制 XPO1 依赖性核输出 (EC50=60.9 nM)。 Eltanexor 在一组白血病细胞系中引起半胱天冬酶依赖性细胞凋亡。 | |||
T27488 |
GSK-690
GSK 690,GSK690 |
Histone Demethylase | Chromatin/Epigenetic |
GSK-690 是一种具有选择性和高效性的赖氨酸去甲基化酶1 (LSD 1) 抑制剂,可诱导急性髓系白血病 (AML) 中白血病干细胞的分化,可用于研究白血病。 | |||
T80676 |
AKE-72
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
AKE-72 是一种 Pan-BCR-ABL 抑制剂,具有抗白血病活性,抑制表达天然 BCR-ABL 或其 T315I 突变体的 Ba/F3 细胞的增殖,可用于研究白血病。 | |||
T64338 |
AKI603
AKI 603,AKI-603 |
Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
AKI603 是一种极光激酶 A 抑制剂,IC50值为 12.3 nM。它对白血病细胞具有很强的抗增殖活性,可用于克服白血病中 BCR-ABL-T315I 耐药性突变。 | |||
T67930 |
CWI1-2
|
Apoptosis | Apoptosis |
CWI1-2 是一种有效的 IGF2BP2 抑制剂,通过结合 IGF2BP2 抑制其与 m6A 修饰的靶转录物的相互作用。CWI1-2 具有抗白血病活性,可诱导细胞凋亡 (apoptosis)和分化。 | |||
T9428 |
HM43239
|
FLT | Angiogenesis; Tyrosine Kinase/Adaptors |
HM43239 是一种具有口服活性和选择性 FLT3抑制剂,IC50值为 1.1 nM (FLT3 野生型)、1.8 nM (FLT3 ITD 突变型) 和 1.0 nM (FLT3 D835Y 突变型)。HM43239 作为可逆的 I 型抑制剂直接抑制 FLT3 的激酶活性,并调节 p-STAT5, p-ERK SYK, JAK1/2 和 TAK1。HM43239 抑制白血病细胞的增殖并诱导其凋亡 (apoptosis)。 | |||
T68736 |
KU-0058948
|
Others | Others |
KU-0058948 is a poly (ADP-ribose) polymerase (PARP) inhibitor that induces cell cycle arrest and apoptosis of primary myeloid leukemic cells and myeloid leukemic cell lines in vitro. | |||
T38718 |
Cytarabine triphosphate
Cytarabine triphosphate,Ara-CTP |
Others | Others |
Cytarabine triphosphate (Ara-CTP), a competitive inhibitor of DNA synthesis and an active metabolite of Cytarabine, exhibits predictive potential for leukemic blasts' chemosensitivity to Cytarabine through intracellular levels. | |||
T82583 |
Deoxyharringtonine
|
Others | Others |
Deoxyharringtonine为从Cephalotaxus属植物中分离的生物碱,具备显著的抗白血病活性。 | |||
T61858 |
HDAC8-IN-3
|
Others | Others |
HDAC8-IN-3 (compound P19) is a highly potent inhibitor of HDAC8, displaying an IC50 value of 9.3 μM and producing thermal stabilization. Moreover, HDAC8-IN-3 exhibits cytotoxicity and induces apoptosis specifically in leukemic cell lines [1]. | |||
T41205 |
3',3'-cGAMP sodium salt
|
Others | Others |
3',3'-cGAMP sodium salt is a STING agonist. Reduces B cell proliferation and induces apoptosis of malignant B cellsin vitro. Suppresses 5TGM1 multiple myeloma xenograft growth in immunodeficient mice, and induces leukemic regression in Eμ-TCL1 mice. | |||
T39482 |
Casein Kinase inhibitor A86
Casein Kinase inhibitor A86 |
Others | Others |
Casein Kinase inhibitor A86 is a highly effective and orally bioavailable inhibitor of casein kinase 1α (CK1α). Additionally, it displays inhibitory actions towards CDK7 (TFIIH) and CDK9 (P-TEFb). Furthermore, Casein Kinase inhibitor A86 demonstrates the ability to induce apoptosis in leukemia cells, portraying substantial anti-leukemic effects. | |||
T39861 |
AS-85
|
Others | Others |
AS-85 is a potent ASH1L histone methyltransferase inhibitor ( IC 50 =0.6 μM) with anti-leukemic activity. AS-85 strongly binds to the ASH1L SET domain, with the K d value of 0.78 μM. | |||
T22104 |
ML-291
|
Others | Others |
ML291 is a sufonamidebenzamide compound that induces the unfolded protein response (UPR) and overwhelms the adaptive capacity of UPR, resulting in apoptosis in various solid cancer models. It activates the PERK/eIF2a/CHOP apoptotic pathway of UPR and reduces leukemic cell burden [1]. | |||
T23975 |
Deacylcortivazol
UNII-3JO09QT49F,DAC,NSC 325316 |
Others | Others |
Deacylcortivazol (DAC) is a potent glucocorticoid. When incubated with glucocorticoid-resistant mutants derived from the glucocorticoid-sensitive human leukemic cell line CEM-C7, DAC caused significant growth inhibition. The cytotoxicity of DAC at concent | |||
T40713 |
Dihydro-5-azacytidine
DHAC,NSC264880,5,6-Dihydro-5-azacytidine |
DNA Methyltransferase | Chromatin/Epigenetic |
Dihydro-5-azacytidine (DHAC) 是一种具有活性的核苷类似物,具有抗白血病活性,可抑制细胞生长,诱导 DNA 低甲基化。Dihydro-5-azacytidine 可用于研究白血病和肿瘤。 | |||
T11313 |
Forodesine hydrochloride
BCX-1777 hydrochloride,Immucillin-H hydrochloride |
Others | Others |
Forodesine hydrochloride (BCX-1777 hydrochloride), a potent inhibitor of human lymphocyte proliferation, effectively induces apoptosis in leukemic cells by elevating dGTP levels. This compound is an orally active, highly potent purine nucleoside phosphorylase (PNP) inhibitor, demonstrating IC50 values between 0.48 to 1.57 nM across human, mouse, rat, monkey, and dog PNP. | |||
T61101 |
FLT3-IN-13
|
Others | Others |
FLT3-IN-13 (compound 20) is a highly effective inhibitor targeting both topoisomerase II and FLT3 proteins in leukemic cells. It exhibits potent activity against these targets, with IC50 values of 2.26 μM for both. Moreover, FLT3-IN-13 induces cell cycle arrest at the G2/M phase and promotes apoptosis. Notably, it displays considerable anticytotoxic activity, specifically against leukemia [1]. | |||
T76185 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg
|
||
N-Myristoyl-Lys-Arg-Thr-Leu-Arg 是一种蛋白激酶 C (PKC) 抑制剂,其 IC50值为 75 μM。N-Myristoyl-Lys-Arg-Thr-Leu-Arg 抑制人白血病细胞系 Jurkat 中 IL-2受体的诱导和 IL-2的产生。 | |||
T41062 |
HXR9
|
||
HXR9 is a cell-permeable peptide that acts as a competitive antagonist of the HOX/PBX interaction. It effectively inhibits the binding between HOX proteins and the transcription factor PBX, specifically in paralogue groups 1 to 8. HXR9 selectively impairs cell proliferation and induces apoptosis in cells with a high expression of the HOXA/PBX3 genes, for instance, MLL-rearranged leukemic cells. | |||
T78733 |
ZLD115
|
Others | Others |
ZLD115(化合物44)为FB23衍生的FTO抑制剂,作为抗白血病药物,对白血病细胞系展示抗增殖效果。 | |||
T63332 |
BCR-ABL-IN-5
|
Others | Others |
BCR-ABL-IN-5 是一种 Bcr-Abl (Breakpoint cluster region-Abelson) 激酶抑制剂,能够作用于 Bcr-AblWT (IC50: 0.014 μM)和 Bcr-AblT3151 (IC50: 0.45 μM),表现出一定的抗白血病细胞增殖作用。 | |||
T80737 |
ZG36
|
Others | Others |
ZG36是一种人类Caseinolytic protease P(ClpP)激动剂,具有非选择性地降解呼吸链复合物和减少线粒体DNA的能力,从而导致线粒体功能衰竭及白血病细胞死亡。此外,ZG36能够抑制异种移植小鼠模型中急性髓细胞性白血病的发展。 | |||
T38428 |
Alisertib sodium
MLN 8237 sodium |
Others | Others |
Alisertib sodium (MLN 8237) is a potent and specific inhibitor (IC50 = 1.2 nM) of Aurora A kinase, an enzyme involved in cell division. By binding to Aurora A kinase, Alisertib sodium disrupts the formation of the mitotic spindle and causes abnormal cell division. At the molecular level, it acts on the AKT/mTOR/AMPK/p38 pathway, leading to the induction of apoptosis and autophagy in leukemic cells. This compound exhibits significant antitumor activity. | |||
T35429 |
AC-4-130
|
Others | Others |
AC-4-130, a powerful inhibitor of the SH2 domain of STAT5, effectively hinders STAT5 activation, dimerization, nuclear translocation, and transcription of genes reliant on STAT5. This compound directly binds to STAT5, ultimately leading to cell cycle arrest and apoptosis in FLT3-ITD-driven leukemic cells. AC-4-130 exhibits notable anti-cancer properties and effectively suppresses abnormal STAT5 activity in acute myeloid leukemia (AML), making it a promising therapeutic option [1]. | |||
T12240 |
nor-NOHA acetate
Nω-Hydroxy-nor-L-arginine acetate |
Apoptosis; Arginase | Apoptosis; Immunology/Inflammation |
nor-NOHA acetate (Nω-Hydroxy-nor-L-arginine acetate) 是一种可逆的精氨酸酶抑制剂,具有抗白血病的作用,对内皮功能障碍、免疫抑制和代谢有效。在缺氧条件下,它可诱导 ARG2 表达细胞的凋亡。 | |||
T15337 |
Forodesine
Immucillin-H,BCX-1777 |
Apoptosis | Apoptosis |
Forodesine (BCX-1777) 是一种具有口服活性和高效性的嘌呤核苷磷酸化酶 (PNP) 抑制剂,是一种新的嘌呤核苷类似物,抑制人类淋巴细胞增殖抑制剂,可通过增加 dGTP 水平而诱导白血病细胞凋亡 (apoptosis),可用于研究皮肤T细胞淋巴瘤。 | |||
T71400 |
Quizartinib HCl
|
Others | Others |
Quizartinib, also know as AC220 and AC010220, is an orally available FLT3 / STK1 inhibitor with potential antineoplastic activity. Class III receptor tyrosine kinase inhibitor AC220 selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell pro... | |||
T36978 |
AS-99 TFA
|
Others | Others |
AS-99 TFA is a first-in-class, potent and selective ASH1L histone methyltransferase inhibitor (IC50= 0.79 μM, Kd= 0.89 μM) with anti-leukemic activity. AS-99 TFA blocks cell proliferation, induces apoptosis and differentiation, downregulates MLL fusion target genes, and reduces the leukemia burden in vivo[1]. AS-99 TFA is tested against a panel of 20 histone methyltransferases, including NSD1, NSD2, NSD3, and SETD2. NO significant inhibition is observed at 50 μM of AS-99 TFA on any of the tested... | |||
T61098 |
RUNX1/ETO tetramerization-IN-1
|
Others | Others |
RUNX1/ETO tetramerization-IN-1 is a small-molecule inhibitor that specifically targets NHR2 of RUNX1/ETO, effectively inhibiting the tetramerization process. With an EC50 value of 0.25 μM, this compound successfully restores gene expression that has been down-regulated by RUNX1/ETO. Furthermore, RUNX1/ETO tetramerization-IN-1 demonstrates promising anti-leukemic activity by inhibiting the proliferation of SKNO-1 cells dependent on RUNX1/ETO and significantly reducing RUNX1/ETO-associated tumor g... | |||
T76893 |
Lusvertikimab
|
||
Lusvertikimab (OSE-127) 是一种人源化IL7R 单克隆抗体。Lusvertikimab 不会被靶细胞内化并阻止 IL7R 异二聚化和随后的下游信号传导。Lusvertikimab 具有抗白血病功效,具有用于 B 细胞前体急性淋巴细胞白血病 (BCP-ALL) 研究的潜力。 | |||
T73529 |
AS-99
|
Others | Others |
AS-99 是首创的、有效的、选择性 ASH1L 组蛋白甲基转移酶抑制剂 (IC50= 0.79 µM,Kd= 0.89 µM),并具有抗白血病活性。AS-99 阻断细胞增殖,诱导细胞凋亡 (apoptosis) 和细胞分化,下调 MLL 融合靶基因,减少体内白血病负担。 | |||
T84480 |
cis-3,4',5-Trimethoxy-3'-hydroxystilbene
|
Others | Others |
cis-3,4',5-Trimethoxy-3'-hydroxystilbene是一种具有多重生物活性的化合物,它能诱导细胞色素c释放到细胞质中,进而与线粒体释放的细胞色素c相关的细胞凋亡过程有关。此外,该化合物还能抑制微管蛋白的聚合。因其这些特性,cis-3,4',5-Trimethoxy-3'-Hydroxystilbene在白血病的研究中有潜在应用价值。 | |||
T82259 |
Grisnilimab setaritox
WT1-RTA |
||
Grisnilimab setaritox (WT1-RTA) 是抗人 T 细胞抗体 (anti-CD7) 与蓖麻毒素 A 链 (RTA) 的结合物。RTA 是一种质量为 30 kda 的肽,能迅速活化 60S 核糖体亚基。Grisnilimab setaritox 对体外 CEM (T 淋巴母细胞白血病) 细胞具有显著细胞毒性,ID50 为 53 pM,并在恒河猴白血病性脑膜炎模型中显示出疗效改善。 | |||
T76213 |
HXR9 hydrochloride
|
||
HXR9 hydrochloride 是一种针对 HOX/PBX 相互作用的细胞渗透性肽类竞争性拮抗剂。它通过阻碍 HOX 蛋白与 PBX,一个与旁系同源基因组 1 至 8 结合的第二转录因子,之间的相互作用来发挥作用。特别地,HXR9 hydrochloride 能够选择性抑制细胞增殖,并在表达 HOXA/PBX3 基因高水平的细胞中,如 MLL 重排的白血病细胞,促进细胞凋亡。 | |||
T83930 |
SJ 11646
|
Others | Others |
SJ11646是一种高效的LCK(淋巴细胞特异性蛋白酪氨酸激酶)降解剂(PROTAC;DC50= 0.00838 pM)。该化合物由Dasatinib作为LCK配体,以及基于苯基谷氨酰亚胺的cereblon结合体组成。它在体外对LCK激活的T细胞急性淋巴细胞白血病(T-ALL)细胞株和初级白血病样本展现出细胞毒性。在体内,SJ11646在源自患者的T-ALL异种移植模型中显示出抗白血病效果。 | |||
T78871 |
PLM-101
|
Others | Others |
PLM-101是一种口服抗癌剂,针对FLT3和RET具有选择性抑制作用,有效抑制急性髓系白血病(AML)细胞。通过抑制RET,PLM-101促使FLT3的自噬降解,并且通过抑制PI3K和Ras/ERK信号通路来发挥其抗白血病的活性。在小鼠MV4-11侧翼异种移植模型中,PLM-101以口服剂量3及10 mg/kg显示出抗肿瘤效果,并且在同种异种移植小鼠模型中,剂量为40 mg/kg(口服)亦展现出明显的抗肿瘤功效。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5888 |
Toddaculin
|
Others | Others |
Toddaculin 是一种天然香豆素,抑制过度的破骨细胞活性并增强成骨细胞分化和矿化。它可诱导白血病细胞分化和凋亡,具有抗炎活性。 | |||
T2S1040 |
Jolkinolide B
|
ERK; IL Receptor; BCL; p38 MAPK; TNF; NF-κB; Akt; Caspase; PI3K; JAK; JNK; STAT; mTOR | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; Immunology/Inflammation; JAK/STAT signaling; MAPK; NF-κB; PI3K/Akt/mTOR signaling; Proteases/Proteasome; Stem Cells |
Jolkinolide B 是一种从 Euphorbia fischeriana Steud 的根中分离出来的具有生物活性的二萜。 Jolkinolide B 诱导癌细胞凋亡。 Jolkinolide B 可用于预防和治疗骨溶解的研究。 | |||
TN2190 |
Scoulerine
|
Apoptosis; Beta-Secretase; BACE; Parasite | Apoptosis; Microbiology/Virology; Neuroscience |
Scoulerine 是抗有丝分裂化合物。它抑制细胞增殖,阻止细胞周期,并诱导癌细胞凋亡。它也是BACE1(淀粉样前体蛋白裂解酶 1) 的抑制剂。 | |||
T7730 |
Aminopterin
APGA,氨基蝶呤,4-Aminofolic acid |
Antifolate | Cell Cycle/Checkpoint |
Aminopterin (4-Aminofolic acid) 是叶酸的 4-氨基衍生物,是叶酸拮抗剂,具有抗癌和免疫抑制活性,用于研究儿童白血病。它催化叶酸还原为四氢叶酸,竞争性抑制二氢叶酸还原酶,Ki 值为 3.7 pM。 | |||
TN2496 |
1,4-Anthraquinone
|
Others | Others |
1,4-Anthraquinone 是一种抗癌药物,在体外与柔红霉素相同纳摩尔范围内阻断核苷转运、抑制大分子合成、诱导 DNA 片段化并降低 L1210 白血病细胞的生长和活力。它被提议为一种用于高效液相色谱 (HPLC) 测定药物制剂中 N-乙酰半胱氨酸 (NAC) 和卡托普利 (CAP) 的新型柱前试剂。 | |||
T6S1315 |
Oroxylin A
千层纸素A,6-Methoxybaicalein,Baicalein 6-methyl ether |
Virus Protease; HIF/HIF Prolyl-Hydroxylase; Autophagy | Autophagy; Chromatin/Epigenetic; Metabolism; Microbiology/Virology |
Oroxylin A (Baicalein 6-methyl ether) 是一种有活性的黄酮,具有较强的抗癌作用。 | |||
T2S2215 |
Crebanine
|
Apoptosis; Others; Akt | Apoptosis; Cytoskeletal Signaling; Others; PI3K/Akt/mTOR signaling |
Crebanine 是来自于韦诺萨千金藤的一种生物碱,通过抑制 MAPKs 和 Akt 信号通路表现出抗炎活性,还具有抗心律失常的作用。它可诱导人类癌细胞的 G1阻滞和凋亡。 | |||
TN4799 |
Piptocarphin F
|
Others | Others |
Piptocarphin F shows strong cytotoxic activities against mouse lymphoid tumor cell line P388. It also shows cytotoxic activity (IC50 3.87-12.5 umol/L) against the human leukemic cell line HL-60. | |||
T83561 |
(2S)-4'-Hydroxy-7-methoxyflavan
|
||
(2S)-4'-Hydroxy-7-methoxyflavan是一种对人白血病Molt 4细胞展示显著细胞毒性的黄烷化合物。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-01006 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, His)
CLECSF7,CLL-1,PRO34150,CLL1,DLEC,CLEC12A,DCAL2,CLECSF11,MICL... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, Hi... | |||
TMPK-01002 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
HECL,DCAL-2,CD303,CLECSF7,DCAL2,CLECSF11,CLL1,CLL-1,CD371,MI... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), B... | |||
TMPK-01004 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, hFc)
DCAL2,HECL,DCAL-2,DLEC,CLECSF11,CLEC12A,CD371,MICL,CLL-1,CLE... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, hF... | |||
TMPK-01003 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Biotinylated
DCAL2,CD371,CLEC12A,CLL-1,MICL,CD303,HECL,PRO34150,CLL1,DLEC... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Bi... | |||
TMPK-00548 |
CLEC12A/MICL/CLL-1 Protein, Cynomolgus, Recombinant (His)
CD371,HECL,CLECSF11,CLEC12A,CD303,CLL-1,PRO34150,DLEC,DCAL2,... |
Cynomolgus | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Cynomolgus, Recombinant (His) is ... | |||
TMPK-00995 |
CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (aa 65-267, His)
HECL,CLL1,CD371,CLL-1,CLEC12A,MICL,DCAL-2,PRO34150,DLEC,CD30... |
Mouse | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (aa 65-267, Hi... | |||
TMPK-01005 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled
DCAL-2,HECL,CLL-1,CLECSF7,CD371,CLEC12A,PRO34150,MICL,CLECSF... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-La... | |||
TMPK-00242 |
IL-3R alpha/CD123 Protein, Human, Recombinant (aa 19-305, His & Avi), Biotinylated
IL3RAY,IL-3R subunit alpha,IL-3 R α,IL-3 R alpha,IL3RA,IL-3 ... |
Human | HEK293 Cells |
Interleukin-3 receptor subunit alpha, also known as IL-3 receptor subunit alpha, IL-3R-alpha, CD123, and IL3RA, is a single-pass type I membrane protein which belongs to the type I cytokine receptor family and Type 5 subfamily.The specific alpha subunit of the interleukin-3 receptor (IL-3Ralpha, CD123) is strongly expressed in various leukemic blasts and leukemic stem cells and seems to be an excellent target for the therapy of leukemias. | |||
TMPK-00592 |
Latexin Protein, Human, Recombinant (His)
ECI,TCI,LXN,MUM |
Human | E. coli |
Latexin, the endogenous protein inhibitor of the A/B subfamily of metallocarboxypeptidases, is expressed in small nociceptive neurons in sensory ganglia and in a subset of neurons in the telencephalon. Recently, the latexin (Lxn) gene was identified as a potential tumor suppressor in several types of solid tumors and lymphoma, and Lxn expression was found to be absent or downregulated in leukemic cells. | |||
TMPJ-01096 |
SLP-76 Protein, Human, Recombinant (His)
LCP2,SH2 domain-containing leukocyte protein of 76 kDa,SLP-7... |
Human | E. coli |
Lymphocyte cytosolic protein 2(LCP2)contains a SAM domain and a SH2 domain. It is highly expressed in spleen, thymus and peripheral blood leukocytes, T-cell and monocytic cell lines, but expressed at lower level in B-cell lines. LCP2 was originally identified as a substrate of the ZAP-70 protein tyrosine kinase following T cell receptor (TCR) ligation in the leukemic T cell line Jurkat. It is phosphorylated after T-cell receptor activation by ZAP70, ITK and TXK, which leads to the up-regulation ... | |||
TMPJ-00709 |
LY6H Protein, Human, Recombinant (His)
Ly-6H,LY6H,Lymphocyte Antigen 6H |
Human | HEK293 Cells |
Lymphocyte Antigen 6H (LY6H) is a novel member of the LY6 family of glycosylphosphatidylinositol-anchored cell surface glycoproteins. LY6H contains one UPAR/Ly6 domain. Human LY6H is synthesized as a 140 amino acid precursor that contains a 25 amino acid signal sequence, 20 amino acid propeptide that is removed in the mature form, and a 90 amino acid mature chain. LY6H is highly expressed in the brain (cerebral cortex, amygdala, hippocampus and subthalamic nucleus) and in acute human leukemic ce... | |||
TMPY-04458 |
TRIB2 Protein, Human, Recombinant (His & GST)
TRIBBLE,tribbles pseudokinase 2,TRIB2,C5FW,FLJ57420,GS3955,T... |
Human | Baculovirus Insect Cells |
Tribbles homolog 2, also known as TRB-2, and Trib2, is a member of the protein kinase superfamily and Tribbles subfamily (Trib1, Trib2, Trib3). The identification of tribbles as regulators of signal processing systems and physiological processes, including development, together with their potential involvement in diabetes and cancer, has generated considerable interest in these proteins. Tribbles have been reported to regulate the activation of some intracellular signalling pathways with roles e... | |||
TMPJ-00669 |
Siglec-5 Protein, Human, Recombinant (His & Flag & hFc)
Sialic acid-binding Ig-like lectin 5,OB-BP2,Obesity-binding ... |
Human | HEK293 Cells |
Human Siglec-5 are Itype(Igtype) lectins belonging to the Ig superfamily,They are characterized by an N terminal Ig-like V type domain which mediates sialic acid binding, followed by varying numbers of Ig-like C2 type domains. SIGLEC5 has also been designated CD170, they are expressed by monocytic or myeloid lineage cells, and also found at high levels in peripheral blood leukocytes, spleen, bone marrow and at lower levels in lymph node, lung, appendix, placenta, pancreas and thymus. SIGLEC5 are... |